|
Dr. Jonas Wang is a Partner of Sycamore Ventures. He focuses on life sciences and biotechnology investments. Prior to joining Sycamore, Jonas was Vice President of Research and Technology at Johnson & Johnson Consumer Products and a Corporate Director of J&J Drug Delivery Technology Resource Center (TRC), responsible for new product technology, patent strategy, competitive intelligence, and new measurement methodology for skin and hair care franchise. Prior to that, he was an Associate Director of Basic Pharmaceutics, the Pharmaceutical Research Institute of Bristol-Myers Squibb Co. In 2001, he participated at the Congressional Business Summit in Washington, D. C., leading the group exploring emerging markets in America. Jonas has over 30 years of experience in pharmaceutical R&D management and business development. He has published extensively in drug delivery technology and received several awards in his field, including the Johnson Medal, the highest technical achievement award at J&J, for one of his inventions: anti-wrinkle cream; the Distinguished Alumni awards from the National Defense Medical Center and University of Iowa. During his career with J&J, Jonas developed more than 10 core technologies, and filed more than 30 business-related patents. He is currently a member of the Boards of Directors of StemCyte, Inc., Xylos Corporation, Z-Kat Asia Inc., U-Systems Inc. Epitomics Inc. and AGT-YNBY, and is also a Board observer of Transave Inc. Jonas received his Ph.D. in Physical Pharmacy from University of Iowa, USA and Pharmacy degree from National Defense Medical Center in Taiwan, Republic of China. | 